Egas Moniz School of Health and Science
Almada, Monte de Caparica, 2829-699, Portugal
NCT Number: NCT06507137
The purpose of the study is to investigate the influence of walking with external visual cues on brain adaptations.
Interested in participating?
Request Info60 year–100 year
All sexes
Interventional
Not applicable
Almada, Monte de Caparica, 2829-699, Portugal
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Walking in a treadmill while synchronizing their steps with fractal external visual cues
Walking in a treadmill while synchronizing their steps with isochronous external visual cues
Walking in a treadmill
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
The fractal scaling exponent quantifies the complexity of a physiological signal and detects the presence of statistical persistence in a given time series. This parameter is calculated using Detrended Fluctuation Analysis (DFA) from each time series (stride time and stride length).
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
CSE is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS). This parameter provides information regarding the level of excitability of the corticospinal tract.
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
SICI is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS). This parameter provides information regarding the level of inhibition of the motor cortex.
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
ICF is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS). This parameter provides information regarding the level of facilitation of the motor cortex.
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
Joint range of motion is measured through a motion capture system and quantifies the excursion of the joint during the gait task in degrees (º).
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
Joint maximum value is measured through a motion capture system and quantifies the maximum joint flexion during the gait task in degrees (º). This measure will be used to calculate joint range of motion (outcome 2).
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
Joint minimum value is measured through a motion capture system and quantifies the minimum joint flexion during the gait task in degrees (º). This measure will be used to calculate joint range of motion (outcome 2).
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
Joint angle during initial contact is measured through a motion capture system and quantifies the angle of the respective joint at the moment the heel touches the ground during a gait cycle (heel strike) in degrees (º).
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
CV is a common linear measure that translates the amount of variability within the signal and is calculated through the standard deviation normalised to the mean from each time series (stride time and stride length).
Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
Co-contraction is the simultaneous activation of the agonist and antagonist muscles during a task. This parameter It is an important mechanism of the central nervous system to regulate joint stability and provide movement accuracy.
Egas Moniz - Cooperativa de Ensino Superior, CRL
Other
Fractal-based Gait Training in Older Adults: Implications to Motor Control and Neuroplasticity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06023407
Alzheimer Disease, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT06718699
Healthy Aging
Erlangen, Germany
View Trial DetailsNCT06718140
Healthy Aging, Mental Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT05539378
Healthy Aging
Zurich, Switzerland
View Trial Details